🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07282080
Recruiting Not applicable

Discover Better Body Composition With Green Light!

NCT07282080 · tracked via the Priya Life Science USA tracker
Sponsor
Efforia, Inc
Phase
Not applicable
Started
2025-08-15
Last updated
2025-12-23

Condition(s) studied

Body Composition

Investigational drug(s) / intervention(s)

EmeraldLED

EmeraldLED: This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm². The green light EmeraldLED therapy provided in this study is set at 525 nm.

Study summary

Investigation into Green Light Therapy study using EmeraldLED for 15-minute sessions, twice a week, to support positive changes in body composition.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: -individuals with eye conditions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Efforia New York New York Recruiting

More Efforia, Inc trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07282080 on ClinicalTrials.gov ↗ ← All trials in the USA